Review



primary antibodies targeting glut4  (Santa Cruz Biotechnology)


Bioz Verified Symbol Santa Cruz Biotechnology is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 96
      Buy from Supplier

    Structured Review

    Santa Cruz Biotechnology primary antibodies targeting glut4
    Fig. 4 Immunohistochemical analysis of <t>Glut4</t> and p-AMPKα expression in masseter muscle cross-sections from diabetic rats with and without 4HR treatment. Photomicrographs of masseter muscle cross-sections stained with anti-Glut4 and anti-p-AMPKα specific antibodies are shown (scale bar = 50 μm; images without counterstaining). The expression levels of Glut4 and p-AMPKα were significantly higher in the STZ/4HR group compared to the STZ group (*P < 0.05, **.**P < 0.001), indicating that 4HR treatment enhances Glut4 and p-AMPKα expression in diabetic muscle tissue (original magnification × 200)
    Primary Antibodies Targeting Glut4, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 973 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies targeting glut4/product/Santa Cruz Biotechnology
    Average 96 stars, based on 973 article reviews
    primary antibodies targeting glut4 - by Bioz Stars, 2026-03
    96/100 stars

    Images

    1) Product Images from "Therapeutic potential of 4-hexylresorcinol in reducing sarcopenia in diabetic masseter muscle."

    Article Title: Therapeutic potential of 4-hexylresorcinol in reducing sarcopenia in diabetic masseter muscle.

    Journal: Maxillofacial plastic and reconstructive surgery

    doi: 10.1186/s40902-025-00457-w

    Fig. 4 Immunohistochemical analysis of Glut4 and p-AMPKα expression in masseter muscle cross-sections from diabetic rats with and without 4HR treatment. Photomicrographs of masseter muscle cross-sections stained with anti-Glut4 and anti-p-AMPKα specific antibodies are shown (scale bar = 50 μm; images without counterstaining). The expression levels of Glut4 and p-AMPKα were significantly higher in the STZ/4HR group compared to the STZ group (*P < 0.05, **.**P < 0.001), indicating that 4HR treatment enhances Glut4 and p-AMPKα expression in diabetic muscle tissue (original magnification × 200)
    Figure Legend Snippet: Fig. 4 Immunohistochemical analysis of Glut4 and p-AMPKα expression in masseter muscle cross-sections from diabetic rats with and without 4HR treatment. Photomicrographs of masseter muscle cross-sections stained with anti-Glut4 and anti-p-AMPKα specific antibodies are shown (scale bar = 50 μm; images without counterstaining). The expression levels of Glut4 and p-AMPKα were significantly higher in the STZ/4HR group compared to the STZ group (*P < 0.05, **.**P < 0.001), indicating that 4HR treatment enhances Glut4 and p-AMPKα expression in diabetic muscle tissue (original magnification × 200)

    Techniques Used: Immunohistochemical staining, Expressing, Staining



    Similar Products

    primary antibodies targeting glut4  (Santa Cruz Biotechnology)
    96
    Santa Cruz Biotechnology primary antibodies targeting glut4
    Fig. 4 Immunohistochemical analysis of <t>Glut4</t> and p-AMPKα expression in masseter muscle cross-sections from diabetic rats with and without 4HR treatment. Photomicrographs of masseter muscle cross-sections stained with anti-Glut4 and anti-p-AMPKα specific antibodies are shown (scale bar = 50 μm; images without counterstaining). The expression levels of Glut4 and p-AMPKα were significantly higher in the STZ/4HR group compared to the STZ group (*P < 0.05, **.**P < 0.001), indicating that 4HR treatment enhances Glut4 and p-AMPKα expression in diabetic muscle tissue (original magnification × 200)
    Primary Antibodies Targeting Glut4, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies targeting glut4/product/Santa Cruz Biotechnology
    Average 96 stars, based on 1 article reviews
    primary antibodies targeting glut4 - by Bioz Stars, 2026-03
    96/100 stars
    		  Buy from Supplier

    Image Search Results


    Fig. 4 Immunohistochemical analysis of Glut4 and p-AMPKα expression in masseter muscle cross-sections from diabetic rats with and without 4HR treatment. Photomicrographs of masseter muscle cross-sections stained with anti-Glut4 and anti-p-AMPKα specific antibodies are shown (scale bar = 50 μm; images without counterstaining). The expression levels of Glut4 and p-AMPKα were significantly higher in the STZ/4HR group compared to the STZ group (*P < 0.05, **.**P < 0.001), indicating that 4HR treatment enhances Glut4 and p-AMPKα expression in diabetic muscle tissue (original magnification × 200)

    Journal: Maxillofacial plastic and reconstructive surgery

    Article Title: Therapeutic potential of 4-hexylresorcinol in reducing sarcopenia in diabetic masseter muscle.

    doi: 10.1186/s40902-025-00457-w

    Figure Lengend Snippet: Fig. 4 Immunohistochemical analysis of Glut4 and p-AMPKα expression in masseter muscle cross-sections from diabetic rats with and without 4HR treatment. Photomicrographs of masseter muscle cross-sections stained with anti-Glut4 and anti-p-AMPKα specific antibodies are shown (scale bar = 50 μm; images without counterstaining). The expression levels of Glut4 and p-AMPKα were significantly higher in the STZ/4HR group compared to the STZ group (*P < 0.05, **.**P < 0.001), indicating that 4HR treatment enhances Glut4 and p-AMPKα expression in diabetic muscle tissue (original magnification × 200)

    Article Snippet: To investigate the expression of specific proteins in the masseter muscle tissues, we conducted immunohistochemical staining using primary antibodies targeting Glut4 (catalog number sc-53566) from Santa Cruz Biotechnology (Santa Cruz, CA, USA), as well as p-AMPKα (catalog number 07–6814) from Merck (Rahway, NJ, USA).

    Techniques: Immunohistochemical staining, Expressing, Staining